Myc signaling was upregulated in CKD but downregulated in dialysis patients toward control expression levels; whereas long-term overexpression of Myc signaling depletes stem cell populations (70), reduction in Myc activity extends health span and reduces organ fibrosis (71). This evidence concerns the gene MYC and chronic kidney disease.